Perverse Incentives — HIV Prevention and the 340B Drug Pricing Program | NEJM - nejm.org

Perspective from The New England Journal of Medicine — Perverse Incentives — HIV Prevention and the 340B Drug Pricing Program

From the Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute (J.L.M., D.S.K.), and the Division of Infectious Diseases, Beth Israel Deaconess Medical C… [+76 chars]

full article...